Addressing worshippers at the Friday prayers of Tehran on April 11, Eslami said the Iranian scientists have developed a radiopharmaceutical that is capable of diagnosing 30 types of cancer.

Apart from Iran, only one or two other countries have the technical know-how to produce that diagnostic pharmaceutical, he said.

In December 2022, the AEOI chief said Iran aims to become a global hub for manufacturing deuterium drugs.

“In a not too distant future we will turn into a hub for manufacturing drugs based on deuterium which are good alternatives to chemical drugs and have lower side effects in comparison (to those drugs),” he stated.

The AEOI launched a second phase of its deuterium production unit in Arak Heavy Water Reactor Facility in central Iran in April 2021.